A doctor looks at notes in a recovery unit at an Apollo Speciality Hospital, operated by Apollo Hospitals Enterprises Ltd., in the Vanagaram area of Chennai, India. (Photographer: Dhiraj Singh/Bloomberg)

Apollo Hospitals Says Capex Completion Will Aid Profitability From FY20

Apollo Hospitals Enterprise Ltd. said its overall revenue and operating margin will go up from the next financial year as India’s largest hospital chain nears its capital expenditure plan.

It opened nearly 14 new hospitals in the last four years, Group Chief Financial Officer Krishnan Akhileswaran told BloombergQuint in an interaction. “From FY20 onwards, we see a good overall expansion in the top line and Ebitda margin as these [new hospital] start maturing,” Akhileswaran said.

The company’s pharmaceutical business, too, has become an important segment in the overall growth, he said.

Other Highlights:

  • Nasik hospital will break even in the fourth quarter.
  • Navi Mumbai hospital will achieve an Ebitda between Rs 20 crore and Rs 25 crore by next year.
  • Apollo Health and Lifestyle Ltd. made significant progress and will break even by second quarter of FY20.

Q3 Results FY19 (YoY)

  • Revenue rises 17 percent to Rs 2,169 crore.
  • Net profit jumps 29 percent to Rs 86.9 crore.
  • Ebitda up 21 percent at Rs 267.9 crore.
  • Ebitda margin expands to 12.3 percent from 11.9 percent.
  • Healthcare revenue rises 16 percent to Rs 1,157 crore.
  • Pharmacy revenue increases 17 percent to Rs 1,012 crore.

Also read: Why Apollo Hospitals Rallied When Peers Tumbled

Watch the full interview here: